Published in Neurology on February 22, 2000
Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease. Clin Interv Aging (2013) 1.69
Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect Immun (2004) 1.36
Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J Cereb Blood Flow Metab (2008) 0.95
Atherosclerotic Carotid Artery Occlusion. Curr Treat Options Cardiovasc Med (2003) 0.91
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology (2000) 0.89
Identification and management of difficult stroke and TIA syndromes. J Neurol Neurosurg Psychiatry (2001) 0.84
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology (2001) 4.84
Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86
Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke (2001) 3.17
Stratified randomization for clinical trials. J Clin Epidemiol (1999) 3.16
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke (2000) 2.72
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology (2011) 2.67
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62
Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol (2001) 2.60
Seasonal fluctuation in the incidence of intracranial aneurysm rupture and its relationship to changing climatic conditions. J Neurosurg (1994) 2.26
Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke (1998) 2.23
Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med (1990) 2.23
Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ (2000) 2.16
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke (2006) 2.07
Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial. Stroke (1988) 2.05
Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry (2005) 1.86
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke (1998) 1.85
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology (2008) 1.78
Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa. Neurology (2006) 1.75
Development of a test battery to identify older drivers at risk for self-reported adverse driving events. J Am Geriatr Soc (1998) 1.74
CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol (2009) 1.72
Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology (2003) 1.67
Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology (2007) 1.66
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65
New anatomical and functional imaging methods. Ann Neurol (1992) 1.61
Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology (1996) 1.58
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology (2005) 1.52
Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol (2011) 1.49
Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology (2000) 1.47
Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology (2003) 1.43
Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology (1989) 1.42
Restriction fragment length polymorphism of the apoprotein A-I-C-III gene cluster in control and stroke-prone white and black subjects: racial differences. Stroke (1992) 1.39
Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation (2001) 1.25
The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke (2000) 1.24
Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke (1999) 1.20
The Alberta Stroke Program Early CT Score in clinical practice: what have we learned? Int J Stroke (2009) 1.19
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2001) 1.17
Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia. Stroke (2001) 1.17
Activation of emergency medical services for acute stroke in a nonurban population: the T.L.L. Temple Foundation Stroke Project. Stroke (2000) 1.17
Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation (2001) 1.16
Insulin resistance and risk for stroke. Neurology (2002) 1.15
Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke (2001) 1.15
A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride--a review. Neurology (1991) 1.15
Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology (2001) 1.15
Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp Brain Res (1968) 1.13
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology (2003) 1.12
Role of recanalization in acute stroke outcome: rationale for a CT angiogram-based "benefit of recanalization" model. AJNR Am J Neuroradiol (2008) 1.11
Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids. J Neurochem (1966) 1.10
Hypertension in acute ischemic strokes. Not to treat. Arch Neurol (1985) 1.05
Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology (2005) 1.01
Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack. Int J Stroke (2009) 0.99
Brain single-photon emission computed tomography. Neurology (1994) 0.99
Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology (1992) 0.99
Transcranial Doppler ultrasound: present status. Neurology (1990) 0.98
Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol (2006) 0.97
Factors associated with early presentation of acute stroke. Stroke (1993) 0.96
A methodological appraisal of research on prognosis after transient ischemic attacks. Stroke (1991) 0.94
Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke (1993) 0.94
Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke (2000) 0.93
Evaluation times for patients with in-hospital strokes. Stroke (1993) 0.93
Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Stroke (1998) 0.93
Is cholesterol a risk factor for stroke?: Yes. Arch Neurol (1999) 0.93
Yield of transcranial Doppler in acute cerebral ischemia. Stroke (1999) 0.93
Deterioration following spontaneous improvement : sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke (2000) 0.92
Acute stroke care in non-urban emergency departments. Neurology (2001) 0.91
A meta-analysis of observational intra-arterial stroke therapy studies using the Merci device, Penumbra system, and retrievable stents. AJNR Am J Neuroradiol (2012) 0.91
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events. Arch Intern Med (1992) 0.90
A prognostic system for transient ischemia or minor stroke. Ann Intern Med (1991) 0.90
Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology (1986) 0.90
Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset. J Neurol Neurosurg Psychiatry (2006) 0.89
Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs). Neurology (2009) 0.88
The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. J Neurol Neurosurg Psychiatry (2004) 0.88
Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program. Stroke (1995) 0.88
Receptor-mediated uptake and 'retroendocytosis' of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim Biophys Acta (1989) 0.88
Long-term heart disease and stroke mortality among former American prisoners of war of World War II and the Korean Conflict: results of a 50-year follow-up. Mil Med (2001) 0.87
Herpes zoster ophthalmicus and delayed ipsilateral cerebral infarction. Neurology (1983) 0.87
Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke. CMAJ (2000) 0.86
Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells. Mol Cell Biochem (2000) 0.86
Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk. J Neurol Neurosurg Psychiatry (2008) 0.86
Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke (1992) 0.85
Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience. Can J Neurol Sci (2005) 0.84
DWI reversal is associated with small infarct volume in patients with TIA and minor stroke. AJNR Am J Neuroradiol (2013) 0.84
Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1997) 0.84
Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis. N Engl J Med (1999) 0.84
Cholesteryl ester hydrolase activity in human symptomatic atherosclerosis. Lipids (1980) 0.84
Utility of magnetic resonance imaging in acute intracerebral hemorrhage. J Neuroimaging (2000) 0.83
Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes? QJM (2003) 0.83
A broad diagnostic battery for bedside transcranial Doppler to detect flow changes with internal carotid artery stenosis or occlusion. J Neuroimaging (2001) 0.82
Asymptomatic carotid bruit and stenosis: a reappraisal. Stroke (1983) 0.82
SPECT imaging of stroke. J Neuroimaging (1995) 0.81
Blood pressure exceeding national guidelines among women after stroke. Stroke (2000) 0.81
Emotional facial paresis with striatocapsular infarction. J Neurol Sci (1990) 0.81
Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. II: Description of study population. Stroke (1986) 0.81
Strokes in Asians and Pacific-Islanders, Hispanics, and Native Americans. Circulation (1991) 0.81
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1995) 0.81
Cholesteryl ester hydrolase activity in mononuclear cells from patients with type II hypercholesterolemia. Atherosclerosis (1984) 0.81